High lifetime risk of cardiovascular disease vs low 10-year Framingham risk score in HIV-infected subjects under ART in Spain: the Coronator study

por Estrada, V, Masiá, M, Iribarren, J, Sanchez-Marcos, C, Lozano, F, Miralles, C, Olalla, J, Santos, J, Bernardino, J, Dronda, F, Domingo, P
Publicado 2012

Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA(®), Because of a Previous Intolerance to cART. PRO-STR Study

por Podzamczer, D., Rozas, N., Domingo, P., Miralles, C., Van den Eynde, E., Romero, A., Deig, E., Knobel, H., Pasquau, J., Antela, A., Clotet, B., Geijo, P., de Castro, E. Rodríguez, Casado, M.A., Muñoz, A., Casado, A.
Publicado 2018

Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy

por Labarga, P, Vispo, ME, Guardiola, JM, Miralles, C, Martín-Carbonero, L, Portu, J, Barreiro, P, Miralles, P, Morello, J, Tellez, MJ, Bancalero, P, Asensi, V, Rallón, NI, Santos, I, Morano, L, Aguirrebengoa, K, Rios, MJ, Rubio, R, Neukam, K, González-Lahoz, J, Soriano, V
Publicado 2010